LathMized™ NAD+
Post-Viral Recovery
If you've had COVID — or any serious viral illness — and you haven't felt right since, you're not imagining it. Post-viral NAD+ depletion is one of the most well-documented metabolic consequences of infection. The fatigue, the brain fog, the feeling that your body won't respond the way it used to — these trace back to a cellular energy deficit that rest alone won't fix.
Does this sound like you?
What this actually does
All claims are based on statistically significant biomarker changes from the RENEWAL-NAD+ placebo-controlled double-blind RCT (NCT07336836).
All benefits listed reflect statistically significant biomarker changes from the RENEWAL-NAD+ placebo-controlled double-blind RCT (NCT07336836) — conducted with the Institute of Systems Biology and published on bioRxiv 2026. Peer review pending.
What's included
Every element of this protocol — including the full dosing schedule, product supply and practitioner support — is available exclusively to Harmover members.
Get the products for this protocol
Both products require member registration and practitioner approval before purchase.
All phase products together — powder for the 5-day intensive repletion and 20-day intermediate maintenance, sublingual tablets for ongoing daily maintenance. Includes your full protocol document, monitoring guidance, and practitioner support.
Free registration · No commitment
Phase 1: 2,000mg/day in four divided doses for 5 days — the highest intensity in the Harmover range, targeting the severe NAD+ depletion of post-viral syndromes. Phase 2 continues at 250mg/day for 20 days.
250mg/day · AM · Days 6–25
Used from Day 26 onwards — 100mg sublingual tablet placed under the tongue each morning. Sustains the NAD+ levels restored across Phases 1 and 2, month after month.
How to get started
Registration is free and takes less than two minutes. A Harmover practitioner reviews your health summary before releasing your personalised protocol access.
- Practitioner Assessment
- Full 3-Phase Protocol Access
- All Three Phase Products
- Enhanced Practitioner Support
Register Free — Get Started
Free to register · No commitment · Ships UK · EU · US · Canada
Backed by a double-blind RCT
The RENEWAL-NAD+ study — conducted with the Institute of Systems Biology, approved by Western IRB (Protocol No. 20215675) — provides the clinical foundation for the LathMized™ platform.
"In a placebo-controlled double-blind trial specifically relevant to the metabolic mechanisms of post-viral syndromes, LathMized™ NAD+ raised intracellular NAD+ levels by 53% in five days. Blood plasma NAD+ was unchanged — confirming cellular delivery. Every participant responded. SIRT1 increased by 32%. Nine of the twelve hallmarks of ageing were positively affected. Zero serious adverse events."
increase · 5 days
responded
significantly changed
events recorded
Questions about the Long COVID & Post-Viral Protocol
Is this suitable if I'm still experiencing active Long COVID symptoms?
Why is Phase 1 only 5 days when other protocols are longer?
What is post-exertional malaise (PEM) and can this help?
Can I take this if I'm also on Long COVID clinic treatment?
How long before I notice changes?
What is the difference between buying products individually versus as a bundle?
Is this a prescription product?
Before you begin
This protocol is a nutritional adjunct — not a treatment for Long COVID or any post-viral condition. It is designed to address a documented nutritional deficiency of NAD+ in individuals with post-viral syndromes, as an addition to — not replacement for — your existing medical care. Please continue all consultations with your GP or specialist and ensure they know you are following this programme.
Ready to start your recovery properly?
Long COVID recovery is not linear and it's not fast. But addressing the NAD+ deficit at its root — with a structured, supervised programme — gives you the best cellular foundation for genuine recovery.
Free to register · No commitment · Ships UK · EU · US · Canada